Gilat's $32 Million Pentagon Order Is Real — It's Just Not the Fix Investors Are Waiting For

On September 9, Gilat Satellite Networks announced that its DataPath subsidiary won an order worth more than $32 million from the U.S. Department of War for DKET transportable satellite-communications systems. The headline reads like a win: a small-cap satellite company landing a Pentagon contract during a military-hardware boom. It is a real order. The question for an investor is what it actually changes, and the honest answer is less than the headline suggests — because the forces that cut Gilat's stock roughly in half over the past four months have little to do with whether it wins defense business.

Start with what the order is. The DKET systems are relocatable ground terminals that work across Ku, Ka, and X-band networks, designed to be moved quickly to alternate locations so high-capacity communications can be restored under shifting operational conditions. They will be delivered over roughly the next twelve months. Gilat's DataPath president frames the demand in those terms: when connectivity has to be established or restored fast, mobility becomes a strategic advantage. That is a credible real-economy story — the transportable-terminal franchise is filling a recurring military need, and it builds on a stream of defense wins Gilat has already reported this year.

Now size it against the company. Gilat is not tiny at this end of the market — market value around $750 million — but its defense segment is still a modest slice of the whole. In the first quarter of 2026, total revenue was $110.5 million, of which defense contributed just $25.4 million. So a $32 million order, delivered over a year, is larger than a full quarter of the defense unit's current revenue. It is meaningful to that franchise. But against a company guiding to roughly $500–520 million in full-year revenue, it is around six to seven percent of the plan, spread across four quarters. It confirms demand; it does not redefine the company.

Which raises the disconnect worth understanding. Gilat is a business that keeps growing — first-quarter revenue rose 20% year over year; second-quarter revenue rose 17% to $122.7 million, with adjusted EBITDA up 31%. Yet the stock sits near its 52-week low at about $9.75, down more than 40% over 120 days and down sharply year to date. A beginner reading that against "a company growing 20%" might think the market is being unfair. Look closer and a different picture emerges.

The stock had tripled over the prior year, swept up in the run-up of "space stocks" ahead of the SpaceX IPO. Hype inflates; then two earnings air pockets deflated it. In February, Gilat beat Wall Street's quarterly estimates but reported earnings quality that worried the market — sales surged 75% in the quarter, yet operating income was roughly flat and GAAP earnings fell year over year. In May, on the first-quarter report, non-GAAP EPS beat while revenue missed, and management chose to hold its full-year 2026 guidance — roughly 13% growth — rather than raise it. Shares fell more than 20% that day. In other words, the collapse was a repricing from a hyped space name into a real hardware vendor whose profit growth lagged its sales growth.

Then came the financing. On August 31, Gilat placed $100 million of five-year convertible notes at a 3.75% coupon, convertible into shares at $16.00 — about a 60% premium to the share price. The stated purpose is accelerating investment in next-generation satellite and space technologies: more growth spending, not cash returned to owners. The note carries a tell about managements' own uncertainty over the share price: if the stock fails to average $15 over a stretch, the coupon steps up to 5%.

Here is where my usual filter — durable, income-producing, cash-flow-backed businesses — does its work, and it is the reason I treat this order with some skepticism rather than excitement. Gilat pays no dividend. Trailing free cash flow is negative; the company spent about $11.4 million on capital expenditures in the last twelve months while generating little surplus operating cash. Management is deliberately buying future growth with borrowed money and, eventually, shareholder dilution. That is an acceptable strategy for a growth stock, but it is the opposite of an income-growth story. The $32 million order does not produce a dividend, does not turn free cash flow positive on its own, and does not resolve the dilution overhang.

So what would actually change the case? The moves that would matter are the ones the stock has been waiting for all year: free cash flow turning durably positive, a decision to start returning capital, or guidance raised with conviction. A six-percent-of-revenue order from a single defense customer — a segment subject to procurement cycles and competition from much larger primes — is not that. It is encouraging evidence that the transportable-terminal franchise has pricing power and repeat demand, a genuinely useful confirmation. But for an investor deciding whether this beaten-down name is a value or a trap, the order is beside the point. The risk-reward is set by whether Gilat can convert its growth into cash and profits for its owners, not by the size of any single contract. Watch for that, not for more headlines.